EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study

Idaira Rodríguez-Santana iD, Tiago Mestre, Ferdinando Squitieri, Rosa Willock, Astri Arnesen, Alison Clarke, Barbara D'Alessio, Alex Fisher, Rebecca Fuller, Jamie L Hamilton, Hayley Hubberstey, Cath Stanley und 6 weitere

European Journal of Neurology · 2023-04 · 30 (4) · 1109-1117

DOI: 10.1111/ene.15645 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Neurology, online erschienen am 08.12.2022. Verfasst von Idaira Rodríguez-Santana und 17 weiteren Autor:innen. Beteiligte Einrichtung: HCD Economics, Cheshire, UK. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose The prevalence of Huntington disease (HD) has increased over time; however, there is a lack of up‐to‐date evidence documenting the economic burden of HD by disease stage. This study provides an estimate of the annual direct medical, nonmedical, and indirect costs associated with HD from participants in the Huntington's Disease Burden of Illness (HDBOI) study in five European countries and the USA.

Methods

The HDBOI is a retrospective, cross‐sectional study. Data collection was conducted between September 2020 and May 2021. Participants were recruited by their HD‐treating physicians and categorized as early stage (ES), mid stage (MS), or advanced stage (AS) HD. Data were collected via three questionnaires: a case report form, completed by physicians who collected health care resource use associated with HD to compute direct medical cost, and optional patient and caregiver questionnaires, which included information used to compute nondirect medical and indirect costs. Country‐specific unit cost sources were used.

Results

HDBOI cost estimates were €12,663 ( n = 2094) for direct medical costs, €2984 ( n = 359) for nondirect medical costs, and €47,576 ( n = 436) for indirect costs. Costs are higher in patients who are at later stages of disease; for example, direct medical costs estimates were €9220 ( n = 846), €11,885 ( n = 701), and €18,985 ( n = 547) for ES, MS, and AS, respectively. Similar trends were observed for nondirect and indirect costs. Costs show large variations between patients and countries.

Conclusions

Cost estimates from the HDBOI study show that people with HD and their caregivers bear a large economic burden that increases as disease progresses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseHumansRetrospective StudiesCross-Sectional StudiesFinancial StressHealth Care CostsEuropeCost of Illness

Stichwörter der Autor:innen

EuropeHuntington diseaseUnited Statescost of illnesseconomic burden

Autor:innen und Institutionen

  • HCD Economics, Cheshire, UK.
  • Ottawa Hospital Research Institute, Ontario, Ottawa, Canada.
  • Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.
  • European Huntington Association, Kristiansand, Norway.
  • Manchester Centre for Genomic Medicine, Manchester, UK.
  • Lega Italiana Ricerca Huntington, Rome, Italy.

ORCID-Profile: Idaira Rodríguez-Santana

Förderung

  • Roche

Zitieren

APA

Rodríguez-Santana, I., Mestre, T., Squitieri, F., Willock, R., Arnesen, A., Clarke, A., D'Alessio, B., Fisher, A., Fuller, R., Hamilton, J. L., Hubberstey, H., Stanley, C., Vetter, L., Winkelmann, M., Doherty, M., Wu, Y., Finnegan, A., & Frank, S. (2023). Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study. European Journal of Neurology, 30(4), 1109-1117. https://doi.org/10.1111/ene.15645

Vancouver

Rodríguez-Santana I, Mestre T, Squitieri F, Willock R, Arnesen A, Clarke A, et al. Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study. European Journal of Neurology. 2023;30(4):1109-1117. doi:10.1111/ene.15645

BibTeX
@article{RodrguezSantana2023,
  author = {Rodríguez-Santana, Idaira and Mestre, Tiago and Squitieri, Ferdinando and Willock, Rosa and Arnesen, Astri and Clarke, Alison and D'Alessio, Barbara and Fisher, Alex and Fuller, Rebecca and Hamilton, Jamie L and Hubberstey, Hayley and Stanley, Cath and Vetter, Louise and Winkelmann, Michaela and Doherty, Maria and Wu, Yunchou and Finnegan, Alan and Frank, Samuel},
  title = {Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {4},
  pages = {1109--1117},
  doi = {10.1111/ene.15645}
}
Kostenlos starten →